Literature DB >> 17415534

The construction of the eukaryotic expression plasmid pcDNA3.1/azurin and the increased apoptosis of U2OS cells transfected with it.

Zhaoming Ye1, Huiqin Peng, Yongming Fang, Jie Feng, Di-Sheng Yang.   

Abstract

In our previous study, we demonstrated that azurin could selectively trigger apoptosis in human osteosarcoma cell line U2OS cells. However, the rate of apoptosis (35.8 +/- 3.2%) is not very high, and azurin is too expensive to obtain readily. To solve these problems, we constructed a eukaryotic expression plasmid containing the azurin gene with an influenza virus haemagglutinin 9 peptide HA epitope tag, and transfected the recombinant plasmid pcDNA3.1(+)/azurin into U2OS cells. RT-PCR and Western blot analysis validated the successful transfection and the expression of the azurin-HA protein. Conspicuous apoptosis of the transfected cells was detected by flow cytometry (FCM) and the DNA ladder test. The apoptosis rate reached 64.3 +/- 13.1%. The transcriptional levels of the Bax and p53 genes increased significantly in U2OS cells transfected with pcDNA3.1(+)/azurin, but the Bcl-2 mRNA level decreased. There was no difference in the levels of Bcl-xl mRNA and Survivin mRNA. We propose that the transfection of the recombinant plasmid pcDNA3.1(+)/azurin can significantly induce apoptosis in U2OS cells. This is closely associated with the up-regulation of the transcriptional level of the Bax and p53 genes, and the down-regulation of that of the Bcl-2 gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415534      PMCID: PMC6275960          DOI: 10.2478/s11658-007-0012-3

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  25 in total

Review 1.  Apoptosis-regulating proteins as targets for drug discovery.

Authors:  J C Reed
Journal:  Trends Mol Med       Date:  2001-07       Impact factor: 11.951

2.  p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.

Authors:  V Budhram-Mahadeo; P J Morris; M D Smith; C A Midgley; L M Boxer; D S Latchman
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

3.  The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia.

Authors:  G S Salomons; H J Brady; M Verwijs-Janssen; J D Van Den Berg; A A Hart; H Van Den Berg; H Behrendt; K Hählen; L A Smets
Journal:  Int J Cancer       Date:  1997-06-11       Impact factor: 7.396

4.  Site-directed mutagenesis of azurin from Pseudomonas aeruginosa enhances the formation of an electron-transfer complex with a copper-containing nitrite reductase from Alcaligenes faecalis S-6.

Authors:  M Kukimoto; M Nishiyama; M Tanokura; M E Murphy; E T Adman; S Horinouchi
Journal:  FEBS Lett       Date:  1996-09-23       Impact factor: 4.124

5.  Novel BNIP1 variants and their interaction with BCL2 family members.

Authors:  H Zhang; J Heim; B Meyhack
Journal:  FEBS Lett       Date:  1999-04-01       Impact factor: 4.124

6.  The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.

Authors:  Tohru Yamada; Masatoshi Goto; Vasu Punj; Olga Zaborina; Kazuhide Kimbara; T K Das Gupta; A M Chakrabarty
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.

Authors:  M Zhou; L Gu; A M Yeager; H W Findley
Journal:  Leukemia       Date:  1998-11       Impact factor: 11.528

8.  Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.

Authors:  Y Tu; F H Xu; J Liu; R Vescio; J Berenson; C Fady; A Lichtenstein
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

9.  Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer.

Authors:  Vasu Punj; Suchita Bhattacharyya; Djenann Saint-Dic; Chenthamarakshan Vasu; Elizabeth A Cunningham; Jewell Graves; Tohru Yamada; Andreas I Constantinou; Konstantin Christov; Bethany White; Gang Li; Dibyen Majumdar; Ananda M Chakrabarty; Tapas K Das Gupta
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

10.  Bacterial battalions join war against cancer.

Authors:  Gunjan Sinha
Journal:  Nat Med       Date:  2003-10       Impact factor: 53.440

View more
  1 in total

1.  Expression Cloning of Recombinant Escherichia coli lacZ Genes Encoding Cytoplasmic and Nuclear β-galactosidase Variants.

Authors:  Homayoun Naderian; Zahra Rezvani; Mohammad Ali Atlasi; Hossein Nikzad; Af de Vries Antoine
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.